Clovis Oncology (CLVS) Misses Q4 EPS Views

FREE Breaking News Alerts from StreetInsider.com!

StreetInsider.com Top Tickers, 4/23/2024

1. TSLA
2. SPY
3. NVDA
4. PPG
5. HDFCB:IN

6. HDB
7. META
8. WIT
9. HDFCAMC:IN
10. CRM

Price: $0.08 --0%

EPS Growth %: +100.0%

Today's EPS Names:
BVFL, MCET, REOS, More

Clovis Oncology (NASDAQ: CLVS) reported Q4 EPS of ($3.12), $0.68 worse than the analyst estimate of ($2.44).

For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.

Sign up for StreetInsider Free!

Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!